In addition, cell cycle progression in astrocytes can be modulated by hyperglycemic conditions, while proliferation and survival of CNS cancer cells is inherently coupled to insulin-dependent PAM signaling [100, 128–130]. This evidence concerns the gene INS and central nervous system cancer.